| http://www.w3.org/ns/prov#value | - Existing therapies such as trastuzumab (Herceptin??) and lapatinib (Tyverb/Tykerb??), a monoclonal antibody inhibitor and a dual EGFR/HER2 kinase inhibitor, respectively, are currently used in the treatment of HER2-positive cancers, although issues with high recurrence and acquired resistance still remain.
|
